$DFTX

$35.50 -$0.17 (0.48%) Live

$DFTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$DFTX Management Team

Ms. Carol Vallone

Independent Chairman of the Board

Age 68

Compensation $195.0K USD

Sex Female

Mr. Robert Barrow

Chief Executive Officer

Director

Age 36

Compensation $2.669M USD

Sex Male

Ms. Brandi Roberts

Chief Financial Officer

Age 51

Compensation -

Sex Female

Mr. Matthew Wiley

Chief Commercial Officer

Age 53

Compensation -

Sex Male

Mr. Mark Sullivan

Chief Legal Officer

Corporate Secretary

Age 53

Compensation $1.161M USD

Sex Male

Mr. Chris Brinzey

IR Contact Officer

Age -

Compensation -

Sex Male

Mr. Andreas Krebs

Independent Vice Chairman of the Board

Age 67

Compensation $185.0K USD

Sex Male

Dr. Daniel Karlin

Chief Medical Officer

Age 45

Compensation $1.330M USD

Sex Male

Name / Title	Age	Compensation	Sex
Ms. Carol Vallone Independent Chairman of the Board	68	$195.0K USD	Female
Mr. Robert Barrow Chief Executive Officer Director	36	$2.669M USD	Male
Ms. Brandi Roberts Chief Financial Officer	51	-	Female
Mr. Matthew Wiley Chief Commercial Officer	53	-	Male
Mr. Mark Sullivan Chief Legal Officer Corporate Secretary	53	$1.161M USD	Male
Mr. Chris Brinzey IR Contact Officer	-	-	Male
Mr. Andreas Krebs Independent Vice Chairman of the Board	67	$185.0K USD	Male
Dr. Daniel Karlin Chief Medical Officer	45	$1.330M USD	Male

Board of Directors

From the proxy statement filed Apr 27, 2026

Directors

serving now

Independent

6 of 7

stated in the proxy

Average tenure

3.7 years

from year joined

CEO also chairs the board

Carol A. Vallone

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Carol A. Vallone Board chair	69	2021 5 years	Independent	Compensation Committee Audit Committee	None stated	$496,827
Andreas Krebs	68	2021 5 years	Independent	Nominating and Corporate Governance Committee Audit Committee	None stated	$484,827
Suzanne Bruhn	62	2022 4 years	Independent	Compensation Committee · Chair Nominating and Corporate Governance Committee	Pliant Therapeutics, Inc., Travere Therapeutics, Inc.	Not stated
Roger Crystal	49	2022 4 years	Independent	Nominating and Corporate Governance Committee · Chair Compensation Committee	None stated	Not stated
David Gryska	70	2023 3 years	Independent	Audit Committee · Chair	Forte Biosciences, Inc.	$458,827
Roger Adsett	57	2026 0 years	Independent	None stated	None stated	Not stated
Robert Barrow CEO	37	2021 5 years	Not independent	None stated	None stated	Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 27, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$DFTX Management Team

Ms. Carol Vallone

Mr. Robert Barrow

Ms. Brandi Roberts

Mr. Matthew Wiley

Mr. Mark Sullivan

Mr. Chris Brinzey

Mr. Andreas Krebs

Dr. Daniel Karlin

Board of Directors

Related-party transactions

No related-party transactions disclosed